Brad Loncar On Areas Of Opportunity In The Healthcare Sector
Brad Loncar weighs in on JNJ, MRNA, PFE, VRTX, IBB, XBI, SRNE, and VIR. He says that investors should be skeptical of biotech companies that suddenly announce clinical trial news as these stocks will eventually be valued on the fundamentals.
Market Overtime
29 Jan 2021
Related videos
05:07
George Seay On The Benefits Of An RIA For Your Investing Path
Market Overtime
27 Jan 2021
06:29
Sel Hardy On What To Watch In The Health Care Sector
The Watch List
16 Nov 2020
04:28
Ted Oakley Talks Healthcare Sector
The Watch List
30 Nov 2020
06:08
TFF Pharmaceuticals CEO Glenn Mattes On Vaccines In Dry Powder Form
The Watch List
15 Jan 2021
08:28
Dan Sheridan Talks Covid Vaccine Stocks
MID-DAY Movers
29 Jan 2021
ON AIR
7:00 amFutures
Brad Loncar On Areas Of Opportunity In The Healthcare Sector
Brad Loncar weighs in on JNJ, MRNA, PFE, VRTX, IBB, XBI, SRNE, and VIR. He says that investors should be skeptical of biotech companies that suddenly announce clinical trial news as these stocks will eventually be valued on the fundamentals.
Market Overtime
29 Jan 2021
Related videos
George Seay On The Benefits Of An RIA For Your Investing Path
Market Overtime
27 Jan 202105:07
Sel Hardy On What To Watch In The Health Care Sector
The Watch List
16 Nov 202006:29
Ted Oakley Talks Healthcare Sector
The Watch List
30 Nov 202004:28
TFF Pharmaceuticals CEO Glenn Mattes On Vaccines In Dry Powder Form
The Watch List
15 Jan 202106:08
Dan Sheridan Talks Covid Vaccine Stocks
MID-DAY Movers
29 Jan 202108:28